{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:27:22Z","timestamp":1791905242097,"version":"4.3.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100762, 32100828"],"award-info":[{"award-number":["32100762, 32100828"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Chikungunya virus (CHIKV), the causative agent of CHIKV fever, is an arthritogenic\n                    <jats:italic>alphavirus<\/jats:italic>\n                    belonging to the\n                    <jats:italic>Togaviridae<\/jats:italic>\n                    family. It is primarily transmitted by\n                    <jats:italic>Aedes aegypti<\/jats:italic>\n                    mosquitoes and has the potential to become a globally pandemic pathogen. Infection with CHIKV typically results in high fever and often debilitating, sometimes chronic polyarthralgia, as well as central nervous system complications. To date, only few highly effective drugs available for treating CHIKV infection or controlling its replication and transmission. Immunotherapeutic strategies and vaccine development are considered promising approaches, particularly nucleic acid-based vaccines, which offer the advantages of rapid development, high efficacy, and precision. In this study, we performed a bibliometric analysis (the literature search was conducted up to June 2025) using data from three major medical databases to explore research trends, geographic and institutional distribution, and key research hotspots in the field of CHIKV immunotherapy and vaccine development. Our findings reveal a rapidly growing body of literature with significant contributions from leading research institutions in the United States, particularly the University of Texas system. Among the various vaccine types studied, live-attenuated vaccines and nucleic acid-based vaccines dominate the field, with the latter showing a marked increase in research attention in recent years.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1692556","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:35:31Z","timestamp":1765348531000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["A bibliometric analysis of vaccine research on Chikungunya virus: contributors, trends, and emerging frontiers"],"prefix":"10.3389","volume":"16","author":[{"given":"Da","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengwei","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03703-w","article-title":"Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns","volume":"31","author":"Ribeiro Dos Santos","year":"2025","journal-title":"Nat Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177322","article-title":"A brief overview of chikungunya-related pain","volume":"994","author":"Goncalves","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61779-6","article-title":"Infection with chikungunya virus in Italy: an outbreak in a temperate region","volume":"370","author":"Rezza","year":"2007","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.689979","article-title":"Molecular epidemiology, evolution and reemergence of chikungunya virus in South Asia","volume":"12","author":"Sharif","year":"2021","journal-title":"Front Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2008051117","article-title":"Structural basis of Chikungunya virus inhibition by monoclonal antibodies","volume":"117","author":"Zhou","year":"2020","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.cell.2019.04.008","article-title":"Molecular basis of arthritogenic alphavirus receptor MXRA8 binding to chikungunya virus envelope protein","volume":"177","author":"Song","year":"2019","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64687-2","article-title":"Neutralizing antibodies against Chikungunya virus and structural elucidation of their mechanism of action","volume":"16","author":"Han","year":"2025","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002423","article-title":"A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease","volume":"7","author":"Powers","year":"2013","journal-title":"PloS Negl Trop Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008061","article-title":"Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins","volume":"15","author":"Krammer","year":"2019","journal-title":"PloS Pathog"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00372-1","article-title":"Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial","volume":"405","author":"Tindale","year":"2025","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.101000","article-title":"Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study","volume":"6","author":"Hamer","year":"2025","journal-title":"Lancet Microbe"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04540-x","article-title":"Mapping the evolution of kainate receptor research over five decades: trends, hotspots, and emerging frontiers","author":"Liu","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1614831","article-title":"Bibliometric analysis of NMDA receptors: 2015-2024","volume":"16","author":"Liu","year":"2025","journal-title":"Front Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsgos.2025.100610","article-title":"Therapeutic shifts and scientific influence in treatment-resistant depression research: A data-driven perspective","volume":"6","author":"Liu","year":"2026","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03812-6","article-title":"Chikungunya virus burden and implications for vaccination programs","volume":"31","author":"Gabriel","year":"2025","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012349","article-title":"The evolutionary and molecular history of a chikungunya virus outbreak lineage","volume":"18","author":"Makalowski","year":"2024","journal-title":"PloS Negl Trop Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/20499361251371110","article-title":"Chikungunya virus: from genetic adaptation to pandemic risk and prevention","volume":"12","author":"Shandhi","year":"2025","journal-title":"Ther Adv Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012904","article-title":"Chikungunya virus in Europe: A retrospective epidemiology study from 2007 to 2023","volume":"19","author":"Mossel","year":"2025","journal-title":"PloS Negl Trop Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0433-2023","article-title":"Bone erosions and joint damage caused by chikungunya virus: a systematic review","volume":"57","author":"Amaral","year":"2024","journal-title":"Rev da Sociedade Bras Med Trop"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-025-01177-8","article-title":"Chikungunya virus and other emerging arthritogenic alphaviruses","author":"de Souza","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1212\/WNL.0000000000002234","article-title":"Chikungunya virus-associated encephalitis: A cohort study on La Reunion Island, 2005-2009","volume":"86","author":"Gerardin","year":"2016","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1826540","article-title":"Cilioretinal artery obstruction as a complication of retinitis caused by chikungunya virus","volume":"30","author":"Provenzano","year":"2022","journal-title":"Ocul Immunol Inflammation"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1497354","article-title":"Chikungunya virus infection in the skin: histopathology and cutaneous immunological response","volume":"16","author":"Salomao","year":"2025","journal-title":"Front Microbiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1055536","article-title":"Histopathological and immunological characteristics of placentas infected with chikungunya virus","volume":"13","author":"Salom\u00e3o","year":"2022","journal-title":"Front Microbiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/0049475520977011","article-title":"Neonatal Chikungunya: A case series","volume":"51","author":"Meena","year":"2020","journal-title":"Trop Doctor"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/v17050704","article-title":"Perinatal mother-to-child chikungunya virus infection: screening of cognitive and learning difficulties in a follow-up study of the chimere cohort on reunion island","volume":"17","author":"Sarton","year":"2025","journal-title":"Viruses"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2007.07.002","article-title":"Molecular and serological diagnosis of Chikungunya virus infection","volume":"55","author":"Grivard","year":"2007","journal-title":"Pathologie Biologie"},{"key":"B28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41572-023-00429-2","article-title":"Chikungunya fever","volume":"9","author":"Bartholomeeusen","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285879","article-title":"Long lasting anti-IgG chikungunya seropositivity in the Mayotte population will not be enough to prevent future outbreaks: A seroprevalence study, 2019","volume":"18","author":"Mossong","year":"2023","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac246","article-title":"Seroepidemiological reconstruction of long-term chikungunya virus circulation in Burkina Faso and Gabon","volume":"227","author":"Lim","year":"2023","journal-title":"J Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/vim.2019.0168","article-title":"Long-term persistence of chikungunya virus-associated manifestations and anti-chikungunya virus antibody in southern Thailand: 5 years after an outbreak in 2008\u20132009","volume":"33","author":"Ninla-aesong","year":"2020","journal-title":"Viral Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v13.i2.89985","article-title":"Long chikungunya? An overview to immunopathology of persistent arthralgia","volume":"13","author":"Silveira-Freitas","year":"2024","journal-title":"World J Virol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2463191","article-title":"Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines","volume":"21","author":"Bardach","year":"2025","journal-title":"Hum Vaccines immunotherapeutics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1434181","article-title":"COVID-19 vaccines: current and future challenges","volume":"15","author":"Mohammadi","year":"2024","journal-title":"Front Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.877845","article-title":"Prospects on repurposing a live attenuated vaccine for the control of unrelated infections","volume":"13","author":"Seo","year":"2022","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/bs.ai.2024.10.008","article-title":"Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapy","volume":"166","author":"Kaushik","year":"2025","journal-title":"Adv Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1692556\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:35:31Z","timestamp":1765348531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1692556\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2025.1692556"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1692556","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"article-number":"1692556"}}